The San Antonio criteria classify polyneuropathy as class I if it does not exhibit any signs or symptoms but has abnormalities on electrophysiologic testing, autonomic testing, or quantitative sensory testing (QST), 1-Clinical screening tests are basic examinations commonly performed at the bedside
Both outcomes are normal at the 0.25 mg dose
Timeline comparison table These are general guidelines
Use Supportive Therapies to Bridge the Gap When you stop GLP-1 medications, your body may still need support adjusting to its new normal. This is where targeted therapies like lipotropic and wellness injections may make a difference
Abdel-Aziz, A
Technical Characteristics Compound name: BPC-157 Full designation: Body Protection Compound-157 Type: Synthetic peptide Form: Lyophilized powder Purity: 98% Regulatory status: Research Use Only (RUO) Classification: Not intended for clinical, therapeutic, or diagnostic use Each batch is tested to ensure identity, purity, and consistency, ensuring reliability in scientific research applications